Advanced Enzyme Technologies Reports Strong Q2 Results and Closes Buyback

Consolidated net profit rose to Rs 483.06 million from Rs 433.26 million, while revenue grew to Rs 2,145.09 million.

Reader Takeaway: Revenue growth and successful buyback execution provide positive momentum, though reclassification complexities remain a notable regulatory watch-point.

What just happened

Advanced Enzyme Technologies released its consolidated financial results for the quarter ended September 30, 2026. The firm saw top-line revenue rise to Rs 2,145.09 million compared to Rs 1,845.28 million in the same period last year. Simultaneously, the company declared the closure of its open-market share buyback program, which saw the firm acquire 2,410,906 shares for Rs 696.96 million, hitting 99.99% of its target.

Why this matters

The steady increase in net profit, combined with the return of capital via the buyback, signals management's confidence in internal cash flows. Shareholders are also seeing a shift in corporate structure as the company moves to reclassify certain members of the promoter group to the public category, which can improve governance transparency metrics as mandated by SEBI.

Promoter Group Reclassification

The board evaluated 13 reclassification requests. Eight individuals, including Jayesh Madhusudan Soni and Shruti Sharad Dhamdhere, were approved as they met regulatory conditions. However, the board rejected requests from five entities, including Advenza Global Limited and Atharva Green Ecotech LLP, noting they did not satisfy the strict requirements under Regulation 31A(3)(b) of the SEBI Listing Regulations.

What to track next

Investors should monitor the formal exchange approvals (BSE/NSE) for the accepted promoter reclassifications. Additionally, the standalone profit growth—which saw a significant jump to Rs 417.05 million from Rs 222.82 million—suggests strong operational efficiency in the parent entity that remains a key focus area for analyst models.